The mobilisation of peripheral blood progenitor cells using chemotherapy, stem cell factor and filgrastim or chemotherapy plus filgrastim alone: a randomised study.
Weaver
A
A
Department of Medical Oncology, Christie Hospital, Manchester, UK.
Woll
P J
PJ
Lind
M
M
Jenkins
B
B
Gill
C
C
Dexter
T M
TM
Testa
N G
NG
Crother
D
D
D000970:Antineoplastic Agents / Q000627:therapeutic use*; D001781:Blood Component Removal; D003520:Cyclophosphamide / Q000627:therapeutic use*; D005260:Female; D000069585:Filgrastim; D016179:Granulocyte Colony-Stimulating Factor / Q000627:therapeutic use*; D019650:Hematopoietic Stem Cell Mobilization / Q000379:methods*; D006801:Humans; D016131:Lymphocyte Subsets; D010051:Ovarian Neoplasms / Q000097:blood / Q000188:drug therapy*; D011994:Recombinant Proteins; D019089:Stem Cell Factor / Q000627:therapeutic use*
D000970:Antineoplastic Agents; D011994:Recombinant Proteins; D019089:Stem Cell Factor; D016179:Granulocyte Colony-Stimulating Factor; D003520:Cyclophosphamide; D000069585:Filgrastim